Viral concentration determination through plaque assays: using traditional and novel overlay systems.
about
Spinal Cord Ventral Horns and Lymphoid Organ Involvement in Powassan Virus Infection in a Mouse ModelA Novel Method to Titrate Herpes Simplex Virus-1 (HSV-1) Using Laser-Based Scanning of Near-Infrared Fluorophores Conjugated Antibodies.The use of Nanotrap particles in the enhanced detection of Rift Valley fever virus nucleoprotein.Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.Antiviral and virucidal activities of Duabanga grandiflora leaf extract against Pseudorabies virus in vitro.The effective rate of influenza reassortment is limited during human infectionAnterograde or Retrograde Transsynaptic Circuit Tracing in Vertebrates with Vesicular Stomatitis Virus VectorsProtein Phosphatase-1 regulates Rift Valley fever virus replicationZika virus inhibits eIF2α-dependent stress granule assembly.Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone.Spliceosome SNRNP200 Promotes Viral RNA Sensing and IRF3 Activation of Antiviral Response.Sorafenib impedes Rift Valley fever virus egress by inhibiting Valosin-containing protein function in the cellular secretory pathway.Interaction of Influenza A Viruses with Oviduct Explants of Different Avian Species.Thieno[2,3-b]pyridine derivatives: a new class of antiviral drugs against Mayaro virus.Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection.Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran.Alterations in the host transcriptome in vitro following Rift Valley fever virus infection.Zika virus: An updated review of competent or naturally infected mosquitoes.Treatment with the NR4A1 agonist cytosporone B controls influenza virus infection and improves pulmonary function in infected mice.Variation at position 350 in the Chikungunya virus 6K-E1 protein determines the sensitivity of detection in a rapid E1-antigen test.Epithelial-derived TGF-β1 acts as a pro-viral factor in the lung during influenza A infection.Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection.Validation of POCKIT™ Dengue Virus Reagent Set for Rapid Detection of Dengue Virus in Human Serum on a Field-Deployable PCR System.Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1.Complete Genome Sequence of a Zika Virus Strain Isolated from the Serum of an Infected Patient in Thailand in 2006.Wolbachia-mediated virus blocking in mosquito cells is dependent on XRN1-mediated viral RNA degradation and influenced by viral replication rate.Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication.North American domestic pigs are susceptible to experimental infection with Japanese encephalitis virus.Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.De Novo DNA Synthesis in Aedes aegypti Midgut Cells as a Complementary Strategy to Limit Dengue Viral Replication.A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression.The Antiviral Drug Arbidol Inhibits Zika Virus.
P2860
Q27468879-F01359C6-F83A-4CA7-ADB8-DE0D60529568Q33794542-008CCB96-4564-41B8-B537-24FAD4465BB2Q35644546-385ED9B5-41FA-4480-8B62-7B9DEF2E8CE5Q35718193-3A853D1D-93FC-463C-9D38-01BE76981690Q36027487-F5EC9596-C4EA-4A70-9673-3B1E9F92C89FQ36272971-878686E3-3B09-4513-B7FF-F85BE4FD6A5CQ36645926-6F5C0889-69D9-4D74-8BA4-925A4310794DQ36668959-C008696D-6177-4E6C-9790-85FC8C9D9FE6Q38157756-F8548B0C-DA63-4389-9CD6-70459F675360Q38158434-06DB43B9-A2F7-475B-B98F-FF00723001B0Q38291551-4FE3CE9F-09E3-45B8-B001-17FCF00DAE08Q38631743-80EA77FF-0CF8-437D-8A00-EDF26BD45016Q38642074-4F64CB52-7223-42C6-BF82-45B41014A45FQ38715937-6BE2DA07-299A-46B1-AE02-E0D4079EC8E3Q39238492-CFE3F8C6-6576-413B-8B6B-BB0C0CA1D03FQ39672712-F183E097-381F-44AE-85A8-6A348A8BE5E7Q40494350-DDB389FF-B1DB-433D-8F7B-295DEFFE7CF5Q40517930-DB6CE68F-79D3-424E-9C4B-F6726F5106A3Q42778332-CE59C9C9-0914-4F26-98CC-8F77A5625E03Q44169953-33DDB009-7E9F-4EF2-971F-924A88C40E5DQ45325947-57E1ACF8-2DC2-4F65-B3E9-834091433289Q47551639-4B3E1E06-40D9-4A9D-87DA-6CD3BBE8DA31Q47601194-929A8F31-826E-424D-915B-EB936F3D8CD4Q48097495-DAF3060C-7354-4748-BF74-BC0C15059CE5Q50045144-23761207-8DFF-4416-AB4A-5BA5CE2DF888Q51335890-858035EC-93E8-47AA-89EE-7A7B4A8E41B6Q51336430-CBBCEE5D-85AF-4B7A-A50D-B816AB5FFE6DQ51745893-240A59A4-5063-41C1-BCF9-E56C6B69208AQ54116240-D7BDB630-292C-41CC-B859-02D09B20285DQ54203597-5F1C04B5-F9F7-4B46-B365-08DB69AEA6CDQ54215285-183A87E6-494D-4A15-B99D-CD587A83753AQ55028744-35F6DB25-9ED6-4B84-8EA2-16C07D8C5BF6Q55038717-D78E38E8-C604-46AF-A33D-BE25D69BC320Q55084371-C076E1DC-9117-47F8-93F1-DE32A9F8AF9A
P2860
Viral concentration determination through plaque assays: using traditional and novel overlay systems.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Viral concentration determinat ...... nal and novel overlay systems.
@ast
Viral concentration determinat ...... nal and novel overlay systems.
@en
Viral concentration determinat ...... nal and novel overlay systems.
@nl
type
label
Viral concentration determinat ...... nal and novel overlay systems.
@ast
Viral concentration determinat ...... nal and novel overlay systems.
@en
Viral concentration determinat ...... nal and novel overlay systems.
@nl
prefLabel
Viral concentration determinat ...... nal and novel overlay systems.
@ast
Viral concentration determinat ...... nal and novel overlay systems.
@en
Viral concentration determinat ...... nal and novel overlay systems.
@nl
P2860
P356
P1476
Viral concentration determinat ...... nal and novel overlay systems.
@en
P2093
P2860
P304
P356
10.3791/52065
P577
2014-11-04T00:00:00Z